CANCER
DEAD

Serial Number

87128871

Owner

Celgene Corporation

Attorney

Camille M. Miller

Filing Date

Aug 5, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CANCER Trademark

Serial Number: 87128871

CANCER is a trademark filed by Celgene Corporation on August 5, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

August 5, 2016

Registration Date

Not Registered

Published for Opposition

January 24, 2017

Goods & Services

Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain blood diseases and cancers

Providing information concerning consumer product safety via government pharmaceutical programs that provide counseling and information to medical professionals, pharmacists and patients, particularly counseling and information on consumer product safety issues pertaining to pharmaceuticals, and distributing printed materials in connection therewith

Providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; health care services, namely, disease management programs that provide counseling and information in the field of pharmaceuticals, and distributing written materials in connection therewith; providing an interactive website featuring medical information that enables users to enter, access, track, monitor and generate health and medical information and reports; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries

Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 28, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 28, 2020 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 24, 2019 EXRA
SOU EXTENSION 5 GRANTED
Aug 23, 2019 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 22, 2019 AITU
SOU EXTENSION 5 FILED
Aug 19, 2019 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 19, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 24, 2019 EXRA
SOU EXTENSION 4 GRANTED
Jan 22, 2019 EX4G
SOU EXTENSION 4 FILED
Jan 22, 2019 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 22, 2019 EEXT
ASSIGNED TO EXAMINER
Oct 5, 2018 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 19, 2018 EXRA
SOU EXTENSION 3 GRANTED
Jul 17, 2018 EX3G
SOU EXTENSION 3 FILED
Jul 17, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 17, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 25, 2018 EXRA
SOU EXTENSION 2 GRANTED
Jan 23, 2018 EX2G
SOU EXTENSION 2 FILED
Jan 23, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 23, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 15, 2017 EXRA
SOU EXTENSION 1 GRANTED
Jul 13, 2017 EX1G
SOU EXTENSION 1 FILED
Jul 13, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 13, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 21, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 24, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jan 24, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 4, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 6, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 6, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 6, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 6, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 23, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 23, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 23, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 22, 2016 GNRN
NON-FINAL ACTION E-MAILED
Nov 22, 2016 GNRT
NON-FINAL ACTION WRITTEN
Nov 22, 2016 CNRT
ASSIGNED TO EXAMINER
Nov 16, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 11, 2016 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 10, 2016 NWOS
NEW APPLICATION ENTERED
Aug 9, 2016 NWAP